SA
MRVI icon

Sanctuary Advisors’s Maravai LifeSciences MRVI Stock Holding History

Sanctuary Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86K Sell
13,789
-2,733
-17% -$11.8K ﹤0.01% 2735
2026
Q1 		$46.8K Sell
16,522
-1,740
-10% -$5.9K ﹤0.01% 2493
2025
Q4 		$59.4K Sell
18,262
-54,134
-75% -$182K ﹤0.01% 2375
2025
Q3 		$208K Sell
72,396
-14,523
-17% -$37.1K ﹤0.01% 2254
2025
Q2 		$209K Buy
+86,919
New +$183K ﹤0.01% 2149

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Sanctuary Advisors's MRVI Position: Q2 2026 in Review

Sanctuary Advisors reduced its Maravai LifeSciences (MRVI) stake by 17% in Q2 2026, selling an estimated $11.8K and leaving 13,789 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Sanctuary Advisors first reported a position in MRVI in Q2 2025 and has held it in 5 quarters since. The position peaked at $209K in Q2 2025. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Sanctuary Advisors held 13,789 shares of Maravai LifeSciences worth $86K as of Q2 2026.
  • Sanctuary Advisors sold 2,733 Maravai LifeSciences shares in Q2 2026, an estimated $11.8K.
  • Maravai LifeSciences made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2735 holding.
  • Sanctuary Advisors first reported a position in Maravai LifeSciences in Q2 2025 and has held it in 5 quarters since.
  • Sanctuary Advisors's Maravai LifeSciences position peaked at $209K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.